I hold these stock.

DYOH (do your own homework.)

To-day there was a slight drop in price, but number of analysts are giving favourable reports.

What triggered my interest was better than expected results and if I am right looking at charts it shows an inverted head and shoulders. Hopefully a good sign. Also the current rate of Share price growth is about 90% pa over the last 5weeks. This is unlikely to continue indefinitely but SP could hit 850p over next few weeks.

To-day at close, there were some large buys of about 5million shares. 40million approx.

Another trigger for me was the following which should increase earnings.

Aviva to form JV in Taiwan with First FinancialAFX
LONDON (Thomson Financial) - Aviva PLC, the UK's largest insurer, said it has entered into a joint venture with First Financial Holding Co Ltd to sell insurance and pension products in Taiwan. The joint venture company, First-Aviva, will distribute long-term savings and pension products in Taiwan through an exclusive agreement with First Financial's flagship unit, First Commercial Bank. Aviva, which will have a 49 pct stake in the joint venture, added that the initial paid up capital of the new company will be 34 mln stg.First Commercial Bank is Taiwan's second largest bank network, with five mln retail customers, it added.TFN.newsdesk@thomson.comkkb/faj/slm




Date: Wednesday 25 Apr 2007
LONDON (ShareCast) - If the message gets home that Aviva will not bid for Prudential, the stock should rebound strongly, especially if Aviva can sustain its current impressive performance. There is still work to be done but, at 794.5p, the shares are a strong buy says the Independent.
Date: Tuesday 24 Apr 2007
LONDON (ShareCast) - Aviva stood out among the risers on a tough day for blue chip stocks. The life insurer posted an upbeat first quarter statement with brokers pleased with the numbers.



DYOH

Aviva set to make 1,000 redundant

Aviva, which employs more than 2,000 people in Ireland, had invited staff to meetings in Dublin, Cork and Galway.

The redundancies could take up to two years to implement, but it is thought no jobs will be lost before March next year.

Not the news we were expecting I hope !

Harry - hardly new news - check post 98.

With AV. and RSA both having trading statements on thursday, any views anyone?
2517

Uncertainty rules atm.

skinny, AV. recovered quite well during the recent market surge upwards, albeit they have now fallen back somewhat, but not to their September lows, whereas RSA had a more muted sp rise and have fallen back near the lows seen in September. With RSA finals in February could be a good time for picking some up, especially with a good divi to come. Just my view.
2517

George - I already own both, but may consider more if they fall below 3 (RSA < 1).

Interim Managemment Statement.


Strong operating performance


Nine months 2011
------------------------------------------------------------------------------------------------
Good momentum in general n General insurance and health net written premiums
insurance of GBP7.0 billion, up 9%.

n Group combined operating ratio improved to 96%.

n UK general insurance sales up 12%: 318,000 new
personal motor customers this year, now more than
two million in total.
-------------------------- --------------------------------------------------------------------
Strong profitability n New business internal rate of return increased
in life insurance to 14%.

n Long term savings sales of GBP23.6 billion, 8%
lower, driven mainly by actions to write less capital-intensive
business, but also due to current market conditions

n UK life and pension sales up 6% to GBP8.1 billion.
-------------------------- --------------------------------------------------------------------
Focused on balance n IFRS net asset value per share increased by 23
sheet in a tough economic pence to 448 pence (HY2011: 425p).
environment
n IGD solvency surplus GBP2.7 billion and central
liquidity GBP2.3 billion at 30 September 2011.

n On track to meet net operational capital generation
target of between GBP1.5 billion and GBP1.8 billion.

n Minimal impairment on our high-quality long-term
asset portfolio.

n Strengthened equity and euro currency hedging providing
additional downside protection.
-------------------------- --------------------------------------------------------------------
Further delivery n On course to meet our financial targets in 2011.
of our strategy
in the third quarter n Market share gains in key UK markets - in individual
annuities, protection and personal motor*.

n Completed sale of RAC for GBP1.0 billion.

n Sale of Aviva Investors business in Australia.

n Sale of Delta Lloyd's loss-making German business.

14:42, Friday 18 November 2011 - Aviva insurance giant, is to raise $400m in capital securities. The securities, which despite their name, will operate almost exactly like bonds, will pay 8.25% and are due for repayment in 2041. An Aviva spokesman told Sharecast that this is the first time Aviva has entered the US retail market and reflects the firm's desire to utilise its listing in New York (Frankfurt: A0DKRK - news) to broaden its financing base. Aviva says it will use the money for "general corporate purposes" and that "proceeds will be counted towards its regulatory capital resources". Shares in Aviva were down 1.45% in early trading

DC - it was announced before the market opened and has been a bit of a dampener - not that the price needs much of an excuse to go lower recently.

It would be good to add some good news to the threads skinny, not much about at the moment. Have a good weekend.

Strong today - just touched 3 +7%

God Bless S&P - S&P Puts Allianz, Aviva, AXA, Generali, Mapfre Units, 10 Other EU Insurers on CreditWatch/Negative

As concern about European sovereign debt crippled markets, Aviva shares were hit on worries about its exposure. Because of the European focus of its business the shares were hit especially hard, as it owns assets across the Continent.

Andrew Moss, chief executive, continues to he happy with the company's strategy and is confident that eurozone leaders will ultimately find a solution to the crisis.

The company continues to make strategic disposals, with the sale of its UK roadside rescue business RAC to Carlyle Group for £1bn completing in September.

The company has also hedged itself against any fall in the single currency. The shares should start to outperform once there is some resolution in Europe However, this could take some time.

The shares remain a buy.

Well if they say so!

Oriel Securities retains its Buy TP 640.00

FY11 part 1 of 5.

Good progress - beating operating targets


Strong operating performance - beating our targets

. Operating profit of £2.5 billion, up 6% on a continuing basis*
. £2.1 billion operating capital generation (FY 2010: £1.7 billion)
. New business internal rate of return increased to 14.4% (FY 2010: 13.3%)
. Group combined operating ratio improved to 96.8% (FY 2010: 97.1%)
. Full year dividend of 26 pence (FY 2010: 25.5 pence)

Profitable growth in life insurance

. Life insurance operating profit up 7% to £2.1 billion (FY 2010: £2.0 billion)
. Long term savings sales of £31.4 billion, 6% lower (FY 2010: £33.6 billion)
. UK life and pension profits up 8% to £920 million (FY 2010: £850 million)

Underwriting excellence driving profitable growth in general insurance

. General insurance operating profit up 3% to £935 million (FY 2010: £904 million)
. General insurance & health net written premiums up 8% to £9.2 billion (FY 2010: £8.5 billion)
. UK general insurance and health profit up 7% to £520 million (FY 2010: £488 million)

Resilience in volatile markets

. Profit before tax of £87 million (FY 2010: £2.4 billion) was mainly impacted by adverse unrealised investment variances
. IFRS NAV resilient at 435p (FY 2010: 454p)
. Estimated IGD surplus of £3.3 billion at 29 February 2012 (31 December 2011: £2.2 billion)

From HL - Aviva plc

Panmure Gordon note:
"Aviva “open to bids for parts of its business” shocker!
Newspaper reports this morning suggest that CEO Andrew Moss has indicated that Aviva is open to offers for its US business. In our view, the US operation has effectively been on the stocks for over 2 years, but that Aviva would not consider letting it go for an indicated 50% discount to the price that it paid for it in 2006. Whilst there may be a strong rationale for such am sale including the consequent capital boost, Solvency II concerns and the European strategic focus, we do not think that current prices for US life businesses (c0.9x US GAAP book value) make a disposal sensible at the current time. Whilst obviously Aviva would consider any serious offer for any part of the business, in our view a suitable offer is unlikely in the shortmedium term.
Storm in a tea cup – Newspaper reports (FT, Times) this morning suggest that CEO Andrew Moss has indicated at an investor conference that Aviva is open to offers US business. This is not new news. Apart from any PLC being open to offers for any part of its business, Aviva indicated a couple of years ago that whilst the US did form part of its 12 operation new strategy, it would like to exit the US if a suitable price could be achieved. At the time we took that to be at a price close to what it paid for the business in 2006 (c£2bn). We are unsure as to where the indicated value of the US business at c£1bn has come from but do not think that Aviva would sell it for that amount.
Benefits if it did? – Putting the issue of price aside for one moment we believe that a disposal of the US operation would be a positive move for Aviva as it would boost its capital position, which was knocked in 2011 by a series of (largely market related) events. In addition it would remove the uncertainty created by the Solvency II issue over US equivalence which has led Pru to suggest that it might redomicile its HQ to Hong Kong if it is not satisfactorily resolved. Lastly a sale of the US operation would enable a greater focus on its core European market.
Investment view – We believe that the shares might rally slightly on today’s news but fall back when it becomes clear that Aviva won’t “give the business away”. That said, the shares are trading at a very low valuation whilst delivering a massive 8.6% dividend yield based on our 2012F which we believe is both sustainable and growing. On other valuation metrics the shares look equally compelling trading at a 43% disc to EV, 0.9x IFRS NTAV, and an EEV Operating P/E of 4.5x or 5.4x on an IFRS basis. These multiples are at a considerable and too great a discount to its peer group. Buy."

Insurance giant Aviva is slightly softer after announcing the departure of three directors from the group executive committee. The trio - Igal Mayer (CEO of Aviva Europe), Richard Hoskins (CEO of Aviva North America) and Alain Dromer (CEO of Aviva Investors) - are all heading for the exit after the group announced plans to reorganise into just two market groups: Developed Markets and Higher Growth Markets. While those three collect their coats, David Barral, the Chief Executive Officer (CEO) of UK & Ireland (UK&I) Life Insurance